Home »
1999 Issues »
64 FR (03/02/1999) » 99-5030. Agency Information Collection Activities; Announcement of OMB Approval; Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products
99-5030. Agency Information Collection Activities; Announcement of OMB Approval; Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products
[Federal Register Volume 64, Number 40 (Tuesday, March 2, 1999)]
[Notices]
[Pages 10155-10156]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-5030]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 97N-484R]
Agency Information Collection Activities; Announcement of OMB
Approval; Establishment Registration and Listing for Manufacturers of
Human Cellular and Tissue-Based Products
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled ``Establishment Registration and
Listing for Manufacturers of Human Cellular and Tissue-Based Products''
has been approved by the Office of Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: JonnaLynn P. Capezzuto, Office of
Information Resources Management (HFA-250), Food and Drug
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.
SUPPLEMENTARY INFORMATION: In the Federal Register of May 14, 1998 (63
FR 26744), the agency announced that the proposed information
collection had been submitted to OMB for review and clearance under 44
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not
required to respond to, a collection of information unless it displays
a currently valid OMB control number. OMB has now approved the
information collection and has assigned OMB control number 0910-0372.
The approval expires on July 31, 2001. A
[[Page 10156]]
copy of the supporting statement for this information collection is
available on the Internet at ``http://www.fda.gov/ohrms/dockets''.
Dated: February 23, 1999.
William K. Hubbard,
Acting Deputy Commissioner for Policy.
[FR Doc. 99-5030 Filed 3-1-99; 8:45 am]
BILLING CODE 4160-01-F
Document Information
- Published:
- 03/02/1999
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 99-5030
- Pages:
- 10155-10156 (2 pages)
- Docket Numbers:
- Docket No. 97N-484R
- PDF File:
-
99-5030.pdf